corsicanto designated activity company week ending  free weekly updates »     signup corsicanto designated activity company company summary corsicanto designated activity company was set up on thursday the th of november  their current address is dublin  and the company status is normal the companys current directors patrick joseph osullivan joseph thomas kennedy and conor dalton have been the director of  other irish companies between them  of which is now closed corsicanto designated activity company has  shareholder this irish company shares its eircode with at least  other companies company vitals company namecorsicanto designated activity company time in business years company number current statusnormal may trade ascorsicanto dac principal activitymanagement activities of holding companies partial addressdublin  documents documentpageseffectivereceivedb change in situation of reg officeb change in directorssecretaryaccount detailsb annual returnconstitutionordinary resolutionthis company has  other documents getting the full picturevisionnetie gives you full details on every business company and director in ireland ni and the ukhighly predictive credit reportscredit score  credit limitslatest financial accountsjudgments registerd if anydirector  owner detailsrealtime risk alertsinsolvency notices  mocsmedia updatespetitionsco  director trace reportsmortgages  chargesdocs filed at cro and much much moretry visionnetie today for free »visionnetie covers all aspects of business risk enabling you to quickly verify existing and new customer details and assess their credit ratings with ease reports start from just €vat  visionnet ltd  amarin corporation plc nasdaqamrn files an k entry into a material definitive agreement  market exclusive sign in join home about us privacy policy disclaimer advertise on market exclusive about marketexclusivecom contributors sitemap submit a scoop contact us become a contributor stock market news stocks analyst ratings insider trading sec filings earnings biotech stocks small caps sign in welcomelog into your accountyour usernameyour password forgot your password sign up welcomeregister for an account your emailyour username a password will be emailed to you password recovery recover your passwordyour email search sign in  joinmy account orders sign inwelcome log into your accountyour usernameyour password forgot your password get helpcreate an account create an accountwelcome register for an accountyour emailyour username a password will be emailed to you password recoveryrecover your passwordyour email a password will be emailed to you market exclusive home about us privacy policy disclaimer advertise on market exclusive about marketexclusivecom contributors sitemap submit a scoop contact us become a contributor stock market news stocks analyst ratings insider trading sec filings earnings biotech stocks small caps home sec filings amarin corporation plc nasdaqamrn files an k entry into a material definitive sec filings amarin corporation plc nasdaqamrn files an k entry into a material definitive agreement byme staff k january    share on facebook tweet on twitter amarin corporation plc nasdaqamrn files an k entry into a material definitive agreement item entry into a material definitive agreement entry into note purchase agreements and pricing of exchangeable note offering on january  corsicanto ii designated activity company a designated activity company formed under the laws of ireland the issuer and a wholly owned subsidiary of amarin corporation plc the company and the company entered into separate privately negotiated purchase agreements the purchase agreements with certain investors the purchasers to which the issuer will issue and sell million in aggregate principal amount of  exchangeable senior notes due  the  notes at an issue price of  the net proceeds from the offering are expected to be million after deducting placement agent fees and estimated offering expenses payable by the company the offering of the  notes is expected to close on january  subject to customary closing conditions the form of purchase agreement is filed as exhibit  to this report and is incorporated herein by reference the  notes will be issued to an indenture the indenture to be entered into by the company the issuer and wilmington trust national association as trustee the trustee the  notes will be the senior unsecured obligations of the issuer and will be guaranteed by the company the  notes will bear interest at a rate of per annum from and including january  payable semiannually in arrears on january and july of each year beginning on july  the  notes will mature on january  unless earlier repurchased redeemed or exchanged at any time after the issuance of the  notes and prior to the close of business on the second business day immediately preceding january  holders may exchange their  notes for american depositary shares of the company ads at their option and at the exchange rate described below if prior to january  a makewhole fundamental change as defined in the indenture occurs and a holder elects to exchange its  notes in connection with such makewhole fundamental change such holder may be entitled to an increase in the exchange rate as described in the indenture the exchange rate will initially be  adss per  principal amount of the  notes equivalent to an initial exchange price of approximately  per ads the exchange price subject to adjustment in certain circumstances the initial exchange price for the  notes represents a premium of approximately  over the last reported sale price of  per share of the companys adss on the nasdaq global market on january  upon exchange the  notes are to be settled in adss the exchange rate is subject to adjustment from time to time upon the occurrence of certain events including but not limited to the payment of cash dividends prior to january  the issuer may not redeem the  notes at its option other than in connection with certain changes in the tax law of a relevant taxing jurisdiction that results in additional amounts as defined in the indenture becoming due with respect to payments andor deliveries on the  notes on or after january  the issuer may redeem for cash all or a portion of the  notes at a redemption price of  of the aggregate principal amount of the  notes to be redeemed plus accrued and unpaid interest to but not including the redemption date if a fundamental change as defined in the indenture occurs holders may require the issuer to repurchase all or part of their  notes for cash at a fundamental change repurchase price equal to  of the aggregate principal amount of the  notes to be repurchased plus accrued and unpaid interest to but not including the fundamental change repurchase date in addition holders of the  notes may require the issuer to repurchase all or any portion of the  notes on january  for cash at a price equal to  of the aggregate principal amount of the  notes to be repurchased plus accrued and unpaid interest to but not including the repurchase date the issuer may elect at its option to cause all or any portion of the  notes to be mandatorily exchanged in whole or in part at any time prior to the close of business on the business day preceding january  if the daily vwap as defined in the indenture equals or exceeds  of the exchange price then in effect which quotient equals approximately  on the date hereof for at least  vwap trading days as defined in the indenture in any  consecutive vwap trading day period the issuer may only exercise its optional exchange rights upon satisfaction of specified equity conditions including that the adss issuable upon exchange of the  notes be eligible for resale without registration by nonaffiliates and listed on the nasdaq global market its related exchanges or the new york stock exchange if the issuer elects to exercise its optional exchange rights on or prior to january  each holder whose  notes are exchanged may upon exchange receive a specified number of additional adss as set forth in the indenture  the indenture will contain customary terms and covenants and events of default if an event of default other than certain events of bankruptcy insolvency or reorganization involving the issuer occurs and is continuing the trustee by notice to the issuer or the holders of at least  in principal amount of the outstanding  notes by notice to the issuer and the trustee may declare  of the principal of and accrued and unpaid interest if any on all of the  notes to be due and payable upon such a declaration of acceleration such principal and accrued and unpaid interest if any will be due and payable immediately upon the occurrence of certain events of bankruptcy insolvency or reorganization involving the issuer  of the principal of and accrued and unpaid interest if any on all of the  notes will become due and payable automatically notwithstanding the foregoing the indenture will provide that to the extent the issuer elects and for up to  days the sole remedy for an event of default relating to certain failures by the issuer or the company as the case may be to comply with certain reporting covenants in the indenture consists exclusively of the right to receive additional interest on the  notes the issuer has agreed to use its commercially reasonable efforts to procure the listing of the  notes on the global exchange market operated under the supervision of the irish stock exchange or on another recognized stock exchange for the purposes of section of the taxes consolidation act  of ireland and within the meaning of section ita  of the united kingdom prior to july  which will be the first interest payment date for the  notes the foregoing descriptions of the  notes and the indenture do not purport to be complete and are qualified in their entirety by reference to the indenture which will include the form of the  note a copy of the indenture which will include the form of the  note is expected to be attached as an exhibit to a current report on form k to be filed by the company following the closing of the  notes offering lazard is acting as financial advisor and placement agent in connection with the  notes offering the company offered the  notes in reliance on the exemption from registration provided by sectiona of the securities act of  as amended the securities act the offer and sale of the  notes did not involve a public offering the solicitation of offers for the  notes was not done by any form of general solicitation or general advertising and offers for the  notes were only solicited from persons believed to be qualified institutional buyers within the meaning of rule a promulgated under the securities act the  notes and any adss that may be issued upon exchange of the  notes will not be registered under the securities act and may not be offered or sold in the united states absent registration under the securities act or an applicable exemption from registration requirements this current report on form k does not constitute an offer to sell or a solicitation of an offer to buy any security and shall not constitute an offer solicitation or sale in any jurisdiction in which such offering would be unlawful item unregistered sales of equity securities the information set forth in item  of this current report on form k is incorporated by reference in this item  item other events consummation of mandatory tender offer for exchangeable notes issued in  to the terms of the indenture dated as of january  by and among the company corsicanto designated activity co fka corsicanto limited a wholly owned subsidiary of the company the  notes issuer and wells fargo bank national association as trustee the  notes indenture the company and the  notes issuer were required to make an offer to purchase for cash the  exchangeable senior notes due  the  notes outstanding under the  notes indenture at a purchase price equal to  of the principal amount thereof plus accrued and unpaid interest thereon to the date of repurchase the mandatory tender offer the mandatory tender offer expired on january  with approximately million aggregate principal amount of  notes validly tendered by the holders thereof and purchased by the company and the  notes issuer for approximately  million as of the date hereof approximately  million aggregate principal amount of  notes remain outstanding  on january  the company issued a press release with respect to the  notes offering and the mandatory tender offer a copy of this press release is furnished as exhibit  hereto forwardlooking statements this current report on form k contains forwardlooking statements concerning the companys expectations anticipations intentions beliefs or strategies regarding the offering of  notes these forwardlooking statements are not promises or guarantees and involve substantial risks and uncertainties among the factors that could cause actual results to differ materially from those described or projected herein are the following financial market conditions and actions by the counterparties to the purchase agreements prior to the closing of the offering of  notes a further list and description of these risks uncertainties and other risks associated with an investment in the company can be found in companys filings with the us securities and exchange commission including its most recent quarterly report on form q existing and prospective investors are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date hereof item financial statements and exhibits d exhibits exhibit no description  form of private placement purchase agreement  press release dated january     about amarin corporation plc nasdaqamrn amarin corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health the company’s lead product vascepa icosapent ethyl capsule is approved by the united states food and drug administration fda for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia the company operates in the business segment of development and commercialization of vascepa this indication for vascepa known as the marine indication is based primarily on the results from the marine study of vascepa in this approved patient population the company sells vascepa principally to wholesalers as well as selected regional wholesalers and specialty pharmacy providers or collectively its distributors that in turn resell vascepa to retail pharmacies for resale to patients and healthcare providers the company markets vascepa in the united states amarin corporation plc nasdaqamrn recent trading information amarin corporation plc nasdaqamrn closed its last trading session down  at  with  shares trading hands please enable javascript to view the comments powered by disqusan ad to help with our costs related articlesmore from author renasant corporation nasdaqrnst files an k submission of matters to a vote of security holders ohio valley banc corp nasdaqovbc files an k submission of matters to a vote of security holders eagle financial services inc otcmktsefsi files an k other events chs inc nasdaqchscl files an k entry into a material definitive agreement ohio valley banc corp nasdaqovbc files an k financial statements and exhibits duluth holdings inc nasdaqdlth files an k submission of matters to a vote of security holders subscribe to our newsletter email  first namelast nameemail a word from the sponsor latest articles pingtan marine enterprise ltd nasdaqpme files an k results of operations and financial condition rayonier advanced materials inc nyseryam files an k financial statements and exhibits armstrong world industries inc nyseawi files an k submission of matters to a vote of security holders recent posts analyst activity – barclays plc raises its price target on godaddy nysegddy to  analyst activity – barclays plc lowers its price target on brinker international nyseeat to  analyst downgrades – drax group plc otcdrxgy stock gets downgraded by citigroup inc from buy to neutral analyst activity – royal bank of canada raises its price target on dominion diamond corporation nyseddc to  renasant corporation nasdaqrnst files an k submission of matters to a vote of security holders sponsored editor picks biotech movers vertex pharmaceuticals incorporated nasdaqvrtx and inovio pharmaceuticals inc nasdaqino july   here’s what just happened with puma biotechnology inc nasdaqpbyi and cymabay july   biotech movers johnson  johnson nysejnj and pfizer inc nysepfe july   popular posts this small nasdaq hidden gem may have a b drug july   weekly biotech report covering – opko health inc nyseopk intercept april   facebook inc – nasdaqfb might be moving away from its april   popular categorysec filingslsestockstech newsbiotech stocksstock market newssmall capsanalyst ratingscanada about usmarket exclusive offers the latest financial news and analysis for selected us stocks and securities we are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions at market exclusive we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices market exclusive is not a registered investment brokerdealer the content on this site is for informational purposes only additionally the content on this site does not represent the views of market exclusive and is solely a representation of the authors who publish them before investing in any security you should do your own due diligence and consult with a registered broker or financial advisorcontact us email protectedfollow us sec filings stocks stock market news tech news biotech stocks featured small caps gold other news oil become a contributor about marketexclusivecom contributors advertise on market exclusive contact us  market exclusive  secgems corsicanto designated activity co data feeds now available excel  csv  java  python etc database learn more corsicanto designated activity co info ownership filings  co corsicanto limited arthur cox building earlsfort terrace dublin   l   ireland     filing datecurrent and former nameschanged on date corsicanto designated activity co central index key cik  state of incorporation l country of incorporation ireland fiscal year end  all related personscompanies filings amarin corp plcuk   amarin pharmaceuticals plc  ethical holdings plc  db corsicanto dac company profile  bloomberg feedback corsicanto dac private company company profile sector health care industry biotech  pharma subindustry biotech corsicanto designated activity company issues debt to repurchase existing debt and finance corporate spending the company raises capital and operates in dublin ireland corporate information address  pembroke house upper pembroke street  dublin  ireland phone  fax  from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data   amarin corporation  current report print email pdf word xls amarin corp plcuk form k received       united states securities and exchange commission washington dc      form k     current report pursuant to section  or d of the securities exchange act of  date of report date of earliest event reported january       amarin corporation plc exact name of registrant as specified in its charter       england and wales      not applicable state or other jurisdiction of incorporation   commission file number   irs employer identification no    pembroke house upper pembroke street  dublin  ireland   not applicable address of principal executive offices   zip code registrants telephone number including area code     not applicable former name or former address if changed since last report     check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   ☐ written communications pursuant to rule  under the securities act  cfr    ☐ soliciting material pursuant to rule a under the exchange act  cfr a   ☐ precommencement communications pursuant to rule db under the exchange act  cfr db   ☐ precommencement communications pursuant to rule ec under the exchange act  cfr ec       item  entry into a material definitive agreement entry into note purchase agreements and pricing of exchangeable note offering on january   corsicanto ii designated activity company a designated activity company formed under the laws of ireland the issuer and a wholly owned subsidiary of amarin corporation plc the company and the company entered into separate privately negotiated purchase agreements the purchase agreements with certain investors the purchasers pursuant to which the issuer will issue and sell  million in aggregate principal amount of  exchangeable senior notes due  the  notes at an issue price of  the net proceeds from the offering are expected to be  million after deducting placement agent fees and estimated offering expenses payable by the company the offering of the  notes is expected to close on january   subject to customary closing conditions the form of purchase agreement is filed as exhibit  to this report and is incorporated herein by reference the  notes will be issued pursuant to an indenture the indenture to be entered into by the company the issuer and wilmington trust national association as trustee the trustee the  notes will be the senior unsecured obligations of the issuer and will be guaranteed by the company the  notes will bear interest at a rate of  per annum from and including january   payable semiannually in arrears on january  and july  of each year beginning on july   the  notes will mature on january   unless earlier repurchased redeemed or exchanged at any time after the issuance of the  notes and prior to the close of business on the second business day immediately preceding january   holders may exchange their  notes for american depositary shares of the company ads at their option and at the exchange rate described below if prior to january   a makewhole fundamental change as defined in the indenture occurs and a holder elects to exchange its  notes in connection with such makewhole fundamental change such holder may be entitled to an increase in the exchange rate as described in the indenture the exchange rate will initially be  adss per  principal amount of the  notes equivalent to an initial exchange price of approximately  per ads the exchange price subject to adjustment in certain circumstances the initial exchange price for the  notes represents a premium of approximately  over the last reported sale price of  per share of the companys adss on the nasdaq global market on january   upon exchange the  notes are to be settled in adss the exchange rate is subject to adjustment from time to time upon the occurrence of certain events including but not limited to the payment of cash dividends prior to january   the issuer may not redeem the  notes at its option other than in connection with certain changes in the tax law of a relevant taxing jurisdiction that results in additional amounts as defined in the indenture becoming due with respect to payments andor deliveries on the  notes on or after january   the issuer may redeem for cash all or a portion of the  notes at a redemption price of  of the aggregate principal amount of the  notes to be redeemed plus accrued and unpaid interest to but not including the redemption date if a fundamental change as defined in the indenture occurs holders may require the issuer to repurchase all or part of their  notes for cash at a fundamental change repurchase price equal to  of the aggregate principal amount of the  notes to be repurchased plus accrued and unpaid interest to but not including the fundamental change repurchase date in addition holders of the  notes may require the issuer to repurchase all or any portion of the  notes on january   for cash at a price equal to  of the aggregate principal amount of the  notes to be repurchased plus accrued and unpaid interest to but not including the repurchase date the issuer may elect at its option to cause all or any portion of the  notes to be mandatorily exchanged in whole or in part at any time prior to the close of business on the business day preceding january   if the daily vwap as defined in the indenture equals or exceeds  of the exchange price then in effect which quotient equals approximately  on the date hereof for at least  vwap trading days as defined in the indenture in any  consecutive vwap trading day period the issuer may only exercise its optional exchange rights upon satisfaction of specified equity conditions including that the adss issuable upon exchange of the  notes be eligible for resale without registration by nonaffiliates and listed on the nasdaq global market its related exchanges or the new york stock exchange if the issuer elects to exercise its optional exchange rights on or prior to january   each holder whose  notes are exchanged may upon exchange receive a specified number of additional adss as set forth in the indenture    the indenture will contain customary terms and covenants and events of default if an event of default other than certain events of bankruptcy insolvency or reorganization involving the issuer occurs and is continuing the trustee by notice to the issuer or the holders of at least  in principal amount of the outstanding  notes by notice to the issuer and the trustee may declare  of the principal of and accrued and unpaid interest if any on all of the  notes to be due and payable upon such a declaration of acceleration such principal and accrued and unpaid interest if any will be due and payable immediately upon the occurrence of certain events of bankruptcy insolvency or reorganization involving the issuer  of the principal of and accrued and unpaid interest if any on all of the  notes will become due and payable automatically notwithstanding the foregoing the indenture will provide that to the extent the issuer elects and for up to  days the sole remedy for an event of default relating to certain failures by the issuer or the company as the case may be to comply with certain reporting covenants in the indenture consists exclusively of the right to receive additional interest on the  notes the issuer has agreed to use its commercially reasonable efforts to procure the listing of the  notes on the global exchange market operated under the supervision of the irish stock exchange or on another recognized stock exchange for the purposes of section  of the taxes consolidation act  of ireland and within the meaning of section  ita  of the united kingdom prior to july   which will be the first interest payment date for the  notes the foregoing descriptions of the  notes and the indenture do not purport to be complete and are qualified in their entirety by reference to the indenture which will include the form of the  note a copy of the indenture which will include the form of the  note is expected to be attached as an exhibit to a current report on form k to be filed by the company following the closing of the  notes offering lazard is acting as financial advisor and placement agent in connection with the  notes offering the company offered the  notes in reliance on the exemption from registration provided by section a of the securities act of  as amended the securities act the offer and sale of the  notes did not involve a public offering the solicitation of offers for the  notes was not done by any form of general solicitation or general advertising and offers for the  notes were only solicited from persons believed to be qualified institutional buyers within the meaning of rule a promulgated under the securities act the  notes and any adss that may be issued upon exchange of the  notes will not be registered under the securities act and may not be offered or sold in the united states absent registration under the securities act or an applicable exemption from registration requirements this current report on form k does not constitute an offer to sell or a solicitation of an offer to buy any security and shall not constitute an offer solicitation or sale in any jurisdiction in which such offering would be unlawful   item  unregistered sales of equity securities the information set forth in item  of this current report on form k is incorporated by reference in this item    item  other events consummation of mandatory tender offer for exchangeable notes issued in  pursuant to the terms of the indenture dated as of january   by and among the company corsicanto designated activity co fka corsicanto limited a wholly owned subsidiary of the company the  notes issuer and wells fargo bank national association as trustee the  notes indenture the company and the  notes issuer were required to make an offer to purchase for cash the  exchangeable senior notes due  the  notes outstanding under the  notes indenture at a purchase price equal to  of the principal amount thereof plus accrued and unpaid interest thereon to the date of repurchase the mandatory tender offer the mandatory tender offer expired on january   with approximately  million aggregate principal amount of  notes validly tendered by the holders thereof and purchased by the company and the  notes issuer for approximately  million as of the date hereof approximately  million aggregate principal amount of  notes remain outstanding    on january   the company issued a press release with respect to the  notes offering and the mandatory tender offer a copy of this press release is furnished as exhibit  hereto forwardlooking statements this current report on form k contains forwardlooking statements concerning the companys expectations anticipations intentions beliefs or strategies regarding the offering of  notes these forwardlooking statements are not promises or guarantees and involve substantial risks and uncertainties among the factors that could cause actual results to differ materially from those described or projected herein are the following financial market conditions and actions by the counterparties to the purchase agreements prior to the closing of the offering of  notes a further list and description of these risks uncertainties and other risks associated with an investment in the company can be found in companys filings with the us securities and exchange commission including its most recent quarterly report on form q existing and prospective investors are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date hereof item  financial statements and exhibits d exhibits   exhibit no    description     form of private placement purchase agreement     press release dated january               signatures pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   date january       amarin corporation plc     by   s john thero       john thero       president and chief executive officer    exhibit index   exhibit no    description     form of private placement purchase agreement     press release dated january      exhibit  form of private placement purchase agreement                      the  undersigned  for itself and on behalf of the beneficial owners listed on exhibit a hereto the  accounts  for whom the undersigned holds contractual and investment authority each account as well as the undersigned if it is acquiring purchased notes as defined below hereunder a  purchaser  enters into this private placement purchase agreement the  agreement  with a corsicanto ii designated activity company a designated activity company incorporated under the laws of ireland the  company  and the wholly owned subsidiary of amarin corporation plc a public limited company incorporated under the laws of england and wales the  guarantor  and b the guarantor on january   whereby the purchaser will purchase the  purchase  the companys  convertible senior notes due  which are guaranteed by the guarantor the  notes  that will be issued pursuant to the provisions of an indenture to be dated as of the closing date as defined herein the  indenture  in the form of exhibit b hereto by and between the company and wilmington trust national association as trustee the  trustee  on and subject to the terms and conditions set forth in this agreement the parties hereto agree as follows article i  purchase of notes subject to the terms set forth in this agreement at the closing as defined herein the undersigned hereby agrees to cause the purchasers to purchase from the company and the company hereby agrees to issue and sell to the purchasers the principal amount of the notes set forth in exhibit a for the cash purchase price specified in exhibit a  the closing of the purchase the  closing  shall occur on a date the  closing date  which the parties intend to be january   at the closing a each purchaser shall deliver or cause to be delivered to the company the purchase price specified on exhibit a hereto and b upon receipt of the purchase price the company shall issue to each purchaser the principal amount of notes specified on exhibit a hereto collectively the  purchased notes  or if there are no accounts the undersigned as the sole purchaser shall deliver to the company the purchase price and upon receipt of the purchase price the company shall deliver to the undersigned the purchased notes provided however that the parties acknowledge that the delivery of the purchased notes to the purchaser may be delayed due to procedures and mechanics within the system of the depository trust company euroclearcrest the irish stock exchange plc or the nasdaq global market  nasdaq  or other events beyond the companys control and that such delay will not be a default under this agreement so long as i the company is using its reasonable best efforts to effect the issuance of one or more global notes representing the purchased notes ii such delay is no longer than five business days and iii interest shall accrue on such purchased notes from january   contemporaneously with or after the closing the company may issue notes to one or more other investors subject to the terms of the indenture lazard frères  co llc  lazard  shall provide instructions to the undersigned for settlement of the purchase the delivery of the purchased notes will be effected via dwac the companys wiring instructions for delivery of the principal amount of purchased notes and dwac settlement instructions will be provided by lazard postpricing article ii  covenants representations and warranties of the purchasers the undersigned hereby covenants as follows and makes the following representations and warranties on its own behalf and where specified below on behalf of each account each of which is and shall be true and correct on the date hereof and at the closing to the company the guarantor and lazard and all such covenants representations and warranties shall survive the closing section   power and authorization each of the undersigned and each purchaser is duly organized validly existing and in good standing under the laws of its jurisdiction of formation and the undersigned has the power authority and capacity to execute and deliver this agreement to perform its obligations hereunder and to consummate the purchase contemplated hereby in each case on behalf of itself and each account if the undersigned is executing this agreement on behalf of accounts a the undersigned has all requisite discretionary and contractual authority to enter into this agreement on behalf of and bind each account and b  exhibit  a hereto is a true correct and complete list of i the name of each account and ii the principal amount of purchased notes to be issued to such account section   valid and enforceable agreement no violations this agreement has been duly executed and delivered by the undersigned and constitutes a valid and legally binding obligation of the undersigned and each purchaser enforceable against the undersigned and each such purchaser in accordance with its terms except that such enforcement may be subject to a bankruptcy insolvency fraudulent transfer reorganization moratorium or other similar laws affecting or relating to enforcement of creditors rights generally and b general principles of equity whether such enforceability is considered in a proceeding at law or in equity the  enforceability exceptions  this agreement and consummation of the purchase will not violate conflict with or result in a breach of or default under i the undersigneds or such purchasers organizational documents ii any agreement or instrument to which the undersigned or such purchaser is a party or by which the undersigned or such purchaser or any of their respective assets are bound or iii any laws regulations or governmental or judicial decrees injunctions or orders applicable to the undersigned or such purchaser section   qualified institutional buyer each purchaser is a qualified institutional buyer within the meaning of rule a promulgated under the securities act section   no affiliates no purchaser is or has been at any time during the consecutive threemonth period preceding the date hereof a director officer or affiliate within the meaning of rule  promulgated under the securities act an  affiliate  of the company or the guarantor section   restricted notes american depository shares and shares each purchaser a acknowledges that the issuance of the purchased notes pursuant to the purchase and the issuance of any american depository shares of the guarantor the  conversion adss  each representing one ordinary share  pence par value per share of the guarantor the  conversion shares  upon conversion of any of the purchased notes the conversion adss and the conversion shares together the  conversion securities  have not been registered or qualified under the securities act or any state securities laws and the purchased notes and conversion securities are being offered and sold in reliance upon exemptions provided in the securities act and state securities laws for transactions not involving any public offering and therefore cannot be sold transferred offered for sale pledged hypothecated or otherwise disposed of unless they are subsequently registered and qualified under the securities act and applicable state laws or unless an exemption from such registration and qualification is available and that evidence of the purchased notes and conversion securities will bear a legend to such effect as specified in the indenture and b is purchasing the purchased notes and conversion securities for investment purposes only for the account of such purchaser and not with any view toward a distribution thereof or with any intention of selling distributing or otherwise disposing of the purchased notes or conversion securities in a manner that would violate the registration requirements of the securities act the undersigned and each purchaser confirms to the company and lazard that it has such knowledge and experience in business matters that the undersigned and each such purchaser is capable of evaluating the merits and risks of an investment in the purchased notes or the conversion securities and of making an informed investment decision and understands that x this investment is suitable only for an investor which is able to bear the economic consequences of losing its entire investment and y the purchase of the purchased notes or the conversion securities by the undersigned and each purchaser is a speculative investment which involves a high degree of risk of loss of the entire investment    section   no illegal transactions each of the undersigned and each purchaser has not directly or indirectly and no person acting on behalf of or pursuant to any understanding with it has disclosed to a third party any information regarding the purchase nor engaged in any transactions in the securities of the company or the guarantor including without limitation any short sales as defined below involving any of the companys or the guarantors securities since the time that the undersigned was first contacted by any of the company the guarantor lazard or any other person regarding the purchase this agreement or an investment in the purchased notes or the company or the guarantor each of the undersigned and such purchaser covenants that neither it nor any person acting on its behalf or pursuant to any understanding with it will disclose to a third party any information regarding the purchase or engage directly or indirectly in any transactions in the securities of the company or the guarantor including short sales prior to the time the transactions contemplated by this agreement are publicly disclosed by the company  short sales  include without limitation all short sales as defined in rule  of regulation sho promulgated under the securities exchange act of  as amended the  exchange act  and all types of direct and indirect stock pledges forward sale contracts options puts calls short sales swaps derivatives and similar arrangements including on a total return basis and sales and other transactions through nonus brokerdealers or foreign regulated brokers solely for purposes of this section  subject to the undersigneds and such purchasers compliance with their respective obligations under the us federal securities laws and the undersigneds and such purchasers respective internal policies a the terms undersigned and purchaser shall not be deemed to include any employees subsidiaries desks groups or affiliates of the undersigned or such purchaser that are effectively walled off by appropriate fire wall information barriers approved by the undersigneds or the purchasers respective legal or compliance department and thus such walled off parties have not been privy to any information concerning the purchase and b the foregoing representations and covenants of this section  shall not apply to any transaction by or on behalf of an account desk or group that was effected without the advice or participation of or such accounts desks or groups receipt of information regarding the purchase provided by the undersigned section   adequate information no reliance the undersigned acknowledges and agrees on behalf of itself and each purchaser that a the undersigned has been furnished with all materials it considers relevant to making an investment decision to enter into the purchase and has had the opportunity to review the guarantors filings and submissions with the sec including without limitation all information filed or furnished pursuant to the exchange act b the undersigned has had a full opportunity to ask questions of the company and the guarantor concerning the company and the guarantor respectively their respective businesses operations financial performances financial conditions and prospects and the terms and conditions of the purchase c the undersigned has had the opportunity to consult with its accounting tax financial and legal advisors to be able to evaluate the risks and consequences involved in the purchase and to make an informed investment decision with respect to such purchase d neither the company nor lazard is acting as a fiduciary or financial or investment adviser to the undersigned or such purchaser and e neither the undersigned nor such purchaser is relying and none of them has relied upon any statement advice whether accounting tax financial legal or other representation or warranty made by the company the guarantor or any of their respective affiliates or representatives including without limitation lazard except for i the publicly available filings and submissions made by the guarantor with the sec under the exchange act and ii the representations and warranties made by the company and the guarantor in this agreement section   no public market each purchaser understands that no public market exists for the purchased notes and that there is no assurance that a public market will ever develop for the purchased notes section   subsequent offers and resales of the purchased notes in ireland each purchaser agrees that a the purchased notes will not be resold or otherwise transferred in ireland i otherwise than in conformity with the prospectus directive ec regulations  as amended of ireland and any rules issued by the central bank of ireland pursuant to section  of the companies act  of ireland    ii otherwise than in conformity with the provisions of the european communities markets in financial instruments regulations  nos  to  as amended including without limitation regulations  and  thereof or any codes of conduct used in connection therewith and the provisions of the investor compensation act  and iii otherwise than in conformity with the provisions of the companies act  of ireland as amended the central bank acts  to  of ireland as amended and any codes of conduct rules made under section  of the central bank act  of ireland b no action may otherwise be taken in ireland in respect of the purchased notes otherwise than in conformity with the provisions of the market abuse regulation eu  and any rules issued by the central bank of ireland pursuant to section  of the companies act  of ireland article iii  covenants representations and warranties of the company and the guarantor each of the company and where specified below the guarantor hereby covenants as follows and makes the following representations and warranties each of which is and shall be true and correct on the date hereof and at the closing to the purchasers and lazard and all such covenants representations and warranties shall survive the closing section   power and authorization each of the company and the guarantor is duly organized validly existing and in good standing under the laws of its jurisdiction of incorporation and has the power authority and capacity to execute and deliver this agreement and the indenture to perform its respective obligations hereunder and thereunder and to consummate the purchase contemplated hereby section   valid and enforceable agreements no violations this agreement has been duly executed and delivered by the company and the guarantor and constitutes a valid and legally binding obligation of the company and the guarantor enforceable against the company and the guarantor in accordance with its terms except that such enforcement may be subject to the enforceability exceptions at the closing the indenture substantially in the form of exhibit  b hereto will have been duly executed and delivered by the company and the guarantor and will govern the terms of the notes and the indenture will constitute a valid and legally binding obligation of the company and the guarantor enforceable against the company and the guarantor in accordance with its terms except that such enforcement may be subject to the enforceability exceptions this agreement the indenture and consummation of the purchase will not violate conflict with or result in a breach of or default under a the memorandum and articles of association the charter bylaws or other organizational documents of the company and the guarantor b any material agreement or instrument to which the company or the guarantor is a party or by which the company or the guarantor or any of their respective assets are bound or c any laws regulations or governmental or judicial decrees injunctions or orders applicable to the company or the guarantor except in the case of clauses b and c where such violations conflicts breaches or defaults would not affect the companys or the guarantors respective businesses or their respective ability to consummate the transactions contemplated hereby in any material respect section   validity of the purchased notes the purchased notes and the guarantee thereof have been duly authorized by the company and the guarantor respectively and when executed and authenticated in accordance with the provisions of the indenture and delivered to the purchaser pursuant to the purchase against delivery of the purchase price in accordance with the terms of this agreement the purchased notes and the guarantee thereof will be valid and legally binding obligations of the company and the guarantor respectively enforceable in accordance with their terms except that such enforcement may be subject to the enforceability exceptions and the purchased notes will not be subject to any preemptive participation rights of first refusal or other similar rights other than any such rights that will be waived prior to the closing assuming the accuracy of each purchasers representations and warranties hereunder the purchased notes a will be issued in the purchase exempt from the registration requirements of the securities act pursuant to section a of the securities act and b will be issued in compliance with all applicable state and federal laws concerning the issuance of the purchased notes    section   validity of underlying american depository shares the purchased notes have an exchange feature whereby the purchased notes may be exchanged for conversion adss in accordance with the terms of the indenture the guarantor has obtained authority under sections  and  of the uk companies act  to issue the conversion shares free from preemption rights or other third party rights and the conversion adss have been duly authorized and reserved by the guarantor for issuance upon exchange of the purchased notes and when issued upon exchange of the purchased notes in accordance with the terms of the purchased notes and the indenture the conversion adss will be validly issued fully paid and nonassessable and the issuance of the conversion adss will not be subject to any preemptive participation rights of first refusal or other similar rights section   listing approval on or within one business day immediately following a conversion date with respect to the purchased notes the conversion adss delivered in connection with such conversion shall be approved for listing on the nasdaq global market subject to a notice of issuance section   disclosure on or before the first business day following the date of this agreement the guarantor shall issue a publicly available press release or file with the sec a current report on form k disclosing all material terms of the purchase section   no litigation  there is no action lawsuit arbitration claim or proceeding pending or to the knowledge of the company and the guarantor threatened against the company or the guarantor that would reasonably be expected to impede the consummation of the transactions contemplated hereby article iv  miscellaneous section   entire agreement this agreement and any documents and agreements executed in connection with the purchase embody the entire agreement and understanding of the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous oral or written agreements representations warranties contracts correspondence conversations memoranda and understandings between or among the parties or any of their agents representatives or affiliates relative to such subject matter including without limitation any term sheets emails or draft documents section   construction references in the singular shall include the plural and vice versa unless the context otherwise requires references in the masculine shall include the feminine and neuter and vice versa unless the context otherwise requires headings in this agreement are for convenience of reference only and shall not limit or otherwise affect the meanings of the provisions hereof neither party nor its respective counsel shall be deemed the drafter of this agreement for purposes of construing the provisions of this agreement and all language in all parts of this agreement shall be construed in accordance with its fair meaning and not strictly for or against either party section   governing law this agreement shall in all respects be construed in accordance with and governed by the substantive laws of the state of new york without reference to its choice of law rules section   counterparts this agreement may be executed in counterparts each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument any counterpart or other signature hereon delivered by facsimile or any standard form of telecommunication or email shall be deemed for all purposes as constituting good and valid execution and delivery of this agreement by such party section   third party beneficiaries this agreement is also intended for the immediate benefit of lazard lazard may rely on the provisions of this agreement including but not limited to the respective covenants representations and warranties of the undersigned each purchaser and the company    in witness whereof each of the parties hereto has caused this agreement to be executed as of the date first above written   undersigned      company        signed by michael w kalb for and on behalf of corsicanto ii designated activity company as its duly authorized and lawfully appointed attorney in its capacities described in the first paragraph hereof     by           name           title         by           name           title     guarantor    signed by john f thero director chief executive officer and president for and on behalf of amarin corporation plc     by           name           title           signature page to purchase agreement corsicanto ii designated activity company  convertible senior notes due  guaranteed by amarin corporation plc exhibit    amarin announces debt restructuring and related private placement of exchangeable senior notes bedminster nj and dublin ireland january    amarin corporation plc nasdaq amrn amarin announced today that it and its wholly owned subsidiary corsicanto ii designated activity company the issuer have entered into separate privately negotiated purchase agreements with certain investors pursuant to which the issuer will issue and sell  million in aggregate principal amount of  exchangeable senior notes due  the  notes which will be guaranteed by amarin at an issue price of  the purchase agreements were entered into in contemplation of the surrender for purchase of approximately  million aggregate principal amount of  exchangeable senior notes due  which were issued in january  by a subsidiary of amarin the  notes as detailed in an amarin press release issued on december   amarin was required by the terms of the indenture governing the  notes to purchase all  notes surrendered to it on january   as of today approximately  million aggregate principal amount of  notes remain outstanding the  notes will be exchangeable into american depositary shares of amarin adss at the option of the holders at an initial exchange rate of  adss per  principal amount of  notes equivalent to an initial exchange price of approximately  per ads subject to adjustment in certain circumstances the exchange price represents a premium of approximately  over the last reported sale price of  per share of amarins ads on the nasdaq global market on january   the transaction is expected to close on january   subject to customary closing conditions the net proceeds from the offering are expected to be  million after deducting placement agent fees and estimated offering expenses payable by amarin a portion of the net proceeds from the offering will replenish approximately  million of cash on hand that amarin used to purchase substantially all of the  notes amarin anticipates that it will use such cash on hand and the remainder of the net proceeds from the offering for general corporate and working capital purposes lazard is acting as financial advisor and placement agent in connection with the  notes offering this announcement is neither an offer to sell nor a solicitation of an offer to buy any of these securities and shall not constitute an offer solicitation or sale in any jurisdiction in which such offer solicitation or sale is unlawful the  notes and the adss issuable upon exchange of the  notes will not be registered under the securities act of  as amended the securities act or the securities laws of any other jurisdiction and may not be offered or sold in the united states absent registration under the securities act or an applicable exemption from registration requirements about amarin amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health amarins product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids amarins clinical program includes a commitment to an ongoing outcomes study vascepa® icosapent ethyl amarins first fdaapproved product is a highlypure epaonly omega fatty acid product available by prescription for more information about vascepa visit wwwvascepacom for more information about amarin visit wwwamarincorpcom forwardlooking statements this press release contains forwardlooking statements concerning amarins expectations anticipations intentions beliefs or strategies regarding the offering of  notes these forwardlooking statements are not promises or guarantees and involve substantial risks and uncertainties among the factors that could cause actual results to differ materially from those described or projected herein are the following financial market conditions and actions by the counterparties to the purchase agreements prior to the closing of the offering of  notes a further list and description of these risks uncertainties and other risks associated with an investment in amarin can be found in amarins filings with the us securities and exchange commission including its most recent quarterly report on form q existing and prospective investors are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date hereof availability of other information about amarin investors and others should note that amarin communicates with its investors and the public using its website wwwamarincorpcom its investor relations website httpwwwamarincorpcominvestorsplashhtml including but not limited to investor presentations and investor faqs us securities and exchange commission filings press releases public conference calls and webcasts the information that amarin posts on these channels and websites could be deemed to be material information as a result amarin encourages investors the media and others interested in amarin to review the information that amarin posts on these channels including amarins investor relations website on a regular basis this list of channels may be updated from time to time on amarins investor relations website and may include social media channels the contents of amarins website or these channels or any other website that may be accessed from amarins website or these channels shall not be deemed incorporated by reference in any filing under the securities act or under the securities and exchange act of  as amended amarin contact information investor relations gene mack investor relations and corporate communications amarin corporation plc in us    investorrelationsamarincorpcom lee m stern trout group in us    lsterntroutgroupcom media inquiries kristie kuhl finn partners in us    kristiekuhlfinnpartnerscom    amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due   pt community skip to main content pt community registersign in search form search home news ptcurrent issue past issues masthead digital edition subscribe pt tv authors about contact us   ingrezza® valbenazine tablets‎ zurampic® lesinurad tabletsplease click for full prescribing information including boxed warning you are herehome amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due  bedminster nj and dublin ireland dec   globe newswire  amarin corporation plc nasdaqamrn the “company” announced today that it is providing a contractual reminder to holders of the outstanding  exchangeable senior notes due  cusip number  ac the “notes” of its wholly owned subsidiary corsicanto designated activity co fka corsicanto limited the “issuer” of which approximately  million principal amount is outstanding that they have the right to surrender their notes for repurchase by the issuer pursuant to their existing option the “optional put” under the indenture governing the notes dated as of january   no new option is offered hereunder the optional put entitles each holder of the notes to require the issuer to purchase all or any part of such holder’s notes on january   the “repurchase date” for cash at a purchase price the “repurchase price” equal to  of the principal amount of the notes plus accrued and unpaid interest thereon up to but excluding the repurchase date the opportunity for each holder of the notes to exercise the optional put commences today at  pm new york city time and expires at  pm new york city time on wednesday january   which is the business day immediately preceding the repurchase date in order to exercise the optional put and receive the repurchase price or withdraw notes previously surrendered a holder must follow the procedures set forth in the optional put company notice which is being delivered to all registered holders of the notes none of the company the issuer or the company’s board of directors or employees has made or is making any representation or recommendation as to whether or not any holder should surrender any notes additional information at the issuer’s request wells fargo bank national association the trustee paying agent and exchange agent for the notes is delivering an optional put company notice to all registered holders of the notes in addition the company and the issuer will file the optional put company notice with a tender offer statement on schedule to with the securities and exchange commission today copies of the optional put company notice and additional information relating to the procedure for the surrender of the notes may be obtained from wells fargo bank national association by calling   about amarin amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health amarins product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids amarins clinical program includes a commitment to an ongoing outcomes study vascepa® icosapent ethyl amarins first fdaapproved product is a highlypure epaonly omega fatty acid product available by prescription for more information about vascepa visit wwwvascepacom for more information about amarin visit wwwamarincorpcom availability of other information about amarin investors and others should note that we communicate with our investors and the public using our company website wwwamarincorpcom our investor relations website httpwwwamarincorpcominvestorsplashhtml including but not limited to investor presentations and investor faqs securities and exchange commission filings press releases public conference calls and webcasts the information that we post on these channels and websites could be deemed to be material information as a result we encourage investors the media and others interested in amarin to review the information that we post on these channels including our investor relations website on a regular basis this list of channels may be updated from time to time on our investor relations website and may include social media channels the contents of our website or these channels or any other website that may be accessed from our website or these channels shall not be deemed incorporated by reference in any filing under the securities act of  or under the securities and exchange act of contact amarin contact information investor relations gene mack amarin corporation plc in us    investorrelationsamarincorpcom lee m stern trout group in us    lsterntroutgroupcom media inquiries kristie kuhl finn partners in us    kristiekuhlfinnpartnerscomfriday december     stay in touch newsletters available pt and drug management daily news pt table of contents monthly contact us editorial j stephen mciver editoradvertising maureen dwyer liberti vice president group publisherproduction dawn flook director of production servicescirculation jackie ott circulation managerwebmaster webmaster industry announcements affimed presents data on firstinclass bcmatargeting immune cell engager afm at asco annual meeting  share buyback week  novartis drug tasigna receives eu approval for inclusion of treatmentfree remission tfr data in product label basilea announces presentation of interim phase a clinical data with anticancer drug candidate bal at asco meeting targovax presents further positive clinical data from tg phase iii trial at  asco annual meeting addex annual general meeting scheduled for  june  valneva to present at jefferies  global healthcare conference in new york targovax announces formal agenda for  capital markets updates in oslo and london lundbeck obtains rights to breakthrough research in alzheimer’s disease veloxis pharmaceuticals as announces agreement with chiesi farmaceutici spa to commercialize envarsus xr in china more from globe newswire current issue of pt july  user login username  password  create new account request new password corsicanto ii designated activity company  ireland  duedil search for a company or director sign insign inproductteamscustomersplansaboutinternationalbloghelptalk to sales    product teams customers plans about contact duedil corsicanto ii designated activity company ieactivereportadd to listkey informationactivitynews  socialpeoplelocationsdirectorsownershipgroupdocumentsfinancialscredit riskturnover— net assets— return on capital employed — debt to capital — detailscompany namecorsicanto ii designated activity companycompany numberielegal entity identifierysdyoplv source company type—incorporation date dec type of accounts filing—latest annual returns  jun  next annual returns due  jun  latest annual accounts — sic  — sic  — websiteadd websitesocial mediaregistered address earlsfort terracedublin irelandtrading addresses and phone numbers find contact information in the locations tab go to locationsdescription corsicanto ii designated activity company was registered on  dec  with its registered office in dublin  the business has a status listed as active it currently has  directors the companys first directors were conor dalton joseph thomas kennedy patrick joseph osullivan corsicanto ii designated activity company has no subsidiaries regulationfinancial conduct authority see the fca status of any company for enterprise users only registered namesfromuntilprevious name jun presentwidgets r us ltd jun  jun widgets were us ltdregistered namesfind out if this company has traded using a different registered namesee sampleabouthelp keep this companys profile up to dateadd a descriptionlocationchoose an addressregistered address earlsfort terracedublin irelandadd trading addressview mapview map get rich data on the companies that matter to you duedil provides company information to help businesses find opportunities and mitigate risk make your business more agile and resilient todayview planslearn moregrow revenuestreamline onboardingminimise riskimprove collaboration× amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due   marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings press release dec    pm est amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due  bedminster nj and dublin ireland dec   globe newswire via comtex  amarin corporation plc quoteszigmancomposite amrn  the company announced today that it is providing a contractual reminder to holders of the outstanding  exchangeable senior notes due  cusip number ac the notes of its wholly owned subsidiary corsicanto designated activity co fka corsicanto limited the issuer of which approximately  million principal amount is outstanding that they have the right to surrender their notes for repurchase by the issuer pursuant to their existing option the optional put under the indenture governing the notes dated as of january   no new option is offered hereunder the optional put entitles each holder of the notes to require the issuer to purchase all or any part of such holders notes on january   the repurchase date for cash at a purchase price the repurchase price equal to  of the principal amount of the notes plus accrued and unpaid interest thereon up to but excluding the repurchase date the opportunity for each holder of the notes to exercise the optional put commences today at  pm new york city time and expires at  pm new york city time on wednesday january   which is the business day immediately preceding the repurchase date in order to exercise the optional put and receive the repurchase price or withdraw notes previously surrendered a holder must follow the procedures set forth in the optional put company notice which is being delivered to all registered holders of the notes none of the company the issuer or the companys board of directors or employees has made or is making any representation or recommendation as to whether or not any holder should surrender any notes additional information at the issuers request wells fargo bank national association the trustee paying agent and exchange agent for the notes is delivering an optional put company notice to all registered holders of the notes in addition the company and the issuer will file the optional put company notice with a tender offer statement on schedule to with the securities and exchange commission today copies of the optional put company notice and additional information relating to the procedure for the surrender of the notes may be obtained from wells fargo bank national association by calling   about amarin amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health amarins product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids amarins clinical program includes a commitment to an ongoing outcomes study vascepar icosapent ethyl amarins first fdaapproved product is a highlypure epaonly omega fatty acid product available by prescription for more information about vascepa visit wwwvascepacom  for more information about amarin visit wwwamarincorpcom  availability of other information about amarin investors and others should note that we communicate with our investors and the public using our company website  wwwamarincorpcom  our investor relations website  httpwwwamarincorpcominvestorsplashhtml  including but not limited to investor presentations and investor faqs securities and exchange commission filings press releases public conference calls and webcasts the information that we post on these channels and websites could be deemed to be material information as a result we encourage investors the media and others interested in amarin to review the information that we post on these channels including our investor relations website on a regular basis this list of channels may be updated from time to time on our investor relations website and may include social media channels the contents of our website or these channels or any other website that may be accessed from our website or these channels shall not be deemed incorporated by reference in any filing under the securities act of  or under the securities and exchange act of  amarin contact information investor relations gene mack amarin corporation plc in us    investorrelationsamarincorpcom lee m stern trout group in us    lsterntroutgroupcom media inquiries kristie kuhl finn partners in us    kristiekuhlfinnpartnerscom copyright c  globenewswire inc all rights reserved quoteszigmancomposite add to watchlist amrn amarin corp plc adr us  us nasdaq     volume m july   p pe rationa dividend yieldna market cap billion rev per employee most popular  the dark side of cruises  cocacola to replace coke zero in us  market snapshot dow ends at record but tech slump weighs on sp  nasdaq  if you can buy only one stock or etf make it this one  barrons buzz how to fix wall street and bankers pay find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest arenault profit leaps but shares decline abelgiums inflation rate picks up pace agerman consumer prices rise faster than expected arussia retaliates to new sanctions by telling us to cut diplomats afrench economy expands  in the second quarter abig six leave border adjustment out of tax principles akids are training to be ceos and spies at these specialized summer camps aamericans are so uncomfortable asking for money that we’ve resorted to this instead aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due   thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street amarin announces contractual reminder of optional put to holders of  million principal amount of outstanding  exchangeable senior notes due  globenewswire dec    pm est bedminster nj and dublin ireland dec   globe newswire  amarin corporation plc nasdaqamrn the company announced today that it is providing a contractual reminder to holders of the outstanding  exchangeable senior notes due  cusip number  ac the notes of its wholly owned subsidiary corsicanto designated activity co fka corsicanto limited the issuer of which approximately  million principal amount is outstanding that they have the right to surrender their notes for repurchase by the issuer pursuant to their existing option the optional put under the indenture governing the notes dated as of january   no new option is offered hereunder the optional put entitles each holder of the notes to require the issuer to purchase all or any part of such holders notes on january   the repurchase date for cash at a purchase price the repurchase price equal to  of the principal amount of the notes plus accrued and unpaid interest thereon up to but excluding the repurchase date the opportunity for each holder of the notes to exercise the optional put commences today at  pm new york city time and expires at  pm new york city time on wednesday january   which is the business day immediately preceding the repurchase date in order to exercise the optional put and receive the repurchase price or withdraw notes previously surrendered a holder must follow the procedures set forth in the optional put company notice which is being delivered to all registered holders of the notes none of the company the issuer or the companys board of directors or employees has made or is making any representation or recommendation as to whether or not any holder should surrender any notes additional information at the issuers request wells fargo bank national association the trustee paying agent and exchange agent for the notes is delivering an optional put company notice to all registered holders of the notes in addition the company and the issuer will file the optional put company notice with a tender offer statement on schedule to with the securities and exchange commission today copies of the optional put company notice and additional information relating to the procedure for the surrender of the notes may be obtained from wells fargo bank national association by calling   if you liked this article you might like biotech premarket movers cempra novavax ionis cempra novavax and ionis pharmaceuticals were among the biotech stock movers in premarket trading on tuesday armie margaret lee feb    am est amarin amrn stock drops after pricing public offering amarin amrn stock was declining after pricing its public offering at a discount annie palmer aug    am edt tetraphase executive profits hours before stock plummets a tetraphase insider executed a welltimed insider stock sale right before the companys share price fell on negative clinical trial results adam feuerstein sep    am edt  stocks ready for breakouts  mustsee charts these stock charts look ready to break out and trade higher from current levels roberto pedone jul    am edt trending amazons shock earnings show that its cashing in on wall streets goodwill amazon falls obamacare repeal fails   things you must know before the market opens ftc seen as set to block rite aid deal these are our  biggest stories on amazons bizarre earnings whiff  foods to avoid if you have high cholesterol advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers